Zenitar Biomedical

Chengdu, China · Founded 2019 · In IPO Registration

Developer of innovative biopharmaceutical technologies designed to accelerate the discovery and commercialization of new drugs. Zenitar Biomedical is based in Chengdu, China and was founded in 2019. Its last reported valuation was $479 million in Nov 2025. It has raised $165 million.

Last reported valuation
$479.0M
Oct 2026
Priced at
—
Total raised
$165.1M
Last round
—

Who backs Zenitar Biomedical?

27 investors
InvestorType
Qiming Venture PartnersVenture capital
5Y CapitalOther
Lanchi VenturesVenture capital
Tencent InvestmentOther
Orinno CapitalOther
Sichuan Venture CapitalOther
Chengdu New Economy Venture CapitalVenture capital
Sichuan Development FundOther
Chengdu Technology Transfer VentureVenture capital
Chengdu Bio-Town InvestmentOther
+ 17 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Zenitar Biomedical investors

27 investors are on record for Zenitar Biomedical, including Qiming Venture Partners, 5Y Capital, Lanchi Ventures and Tencent Investment.

Free account
More of Zenitar Biomedical with a free account
  • ·The complete investor list: 27 names
  • ·Watch Zenitar Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 27 firms already write checks for companies like Zenitar Biomedical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View